Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan -- Ignore unavailable to you. Want to Upgrade?

To: Kramer who wrote (332)	6/26/1999 3:24:00 PM
From: Kramer	Read Replies (1) \| Respond to of 441

I'm patiently waiting to see how much we are going to get awarded. Every $60,000 is a penny EPS. I would think a half million in damages would sound pretty good (ie: 8 cents EPS.!!!) Normally I would think an award such as this is just a nice blip but the fact that this signals the end of those nagging legal expenses, I'm considering it more structural. Hmmm...next year there will be 10 cents less in legal expenses and an extra 3 cents from closing the NJ facility and maybe 5 cents extra profit from the Bot Tox being produced in Tampa -- ie: an extra 18 cents next year without even considering revenue growth!!! Add in the 8 cents from the lawsuit and the neog fundamentals are going to look real good!!! Have you ever done any discounted cash flow analysis? At some point this baby going to go. Although we are going to probably have to wait until an aquisition can prove to the market that neog management knows what to do with the cash.